The effect of ivermectin on geohelminth frequency (i.e. as used in the onchocerciasis control program in Colombia);Impacto de la ivermectina sobre las geohelmintiasis en el foco de oncocercosis en Colombia

Revista de Salud Publica

Volumn 14, Issue 4, 2012, Pages 681-694

  Knudson, Angélica ^a   Ariza, Yoseth ^a,b   López, Myriam C ^a   Fajardo, Oscar S ^a   Reyes, Patricia ^a   Moncada, Ligia I ^a   Duque, Sofía ^c   Álvarez, Carlos A ^a   Nicholls, Rubén S ^a,c  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD ICESI   (Colombia)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

Colombia; Health education; Helminthiasis; Ivermectin; OEPA; Onchocerciasis; Rural sanitation

Indexed keywords

ANTIPARASITIC AGENT; IVERMECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLOMBIA; FEMALE; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; MIDDLE AGED; ONCHOCERCIASIS; PRESCHOOL CHILD; PROGRAM EVALUATION; PUBLIC HEALTH; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; COLOMBIA; FEMALE; HUMANS; INFANT; IVERMECTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ONCHOCERCIASIS; PROGRAM EVALUATION; YOUNG ADULT;

EID: 84878310086     PISSN: 01240064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organization (WHO). Action against worms. Disponible en: Consultado mayo de 2011.
2. World Health Organization (WHO). Neglected tropical diseases. Hidden successes emerging opportunities. WHO/CDS/NTD/. 2006.
3. Baker MC, Mathieu E, Fleming FM, Deming M, King JD, Garba A, et al. Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework. Lancet.2010;375(9710):231-38.
4. De Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 2003;19:547-51.
5. Organización Panamericana de la Salud. Control de helmintiasis en niños en edad escolar: Una guía para gerentes de programas de control. Washington: Organización Panamericana de la Salud. 2009; p. 64.
6. World Health Organization (WHO). Prevention and control of Schistosomiasis and Soil Transmitted Helminth Infections. Preliminary estimates of the number of children treated with albendazole or mebendazole. Weekly Epidemiological Record. 2006;81:145-64.
7. Cáceres E, Castaño De Romero L, Estupiñán D, López MC, Páez S, Pinilla CA, et al. En: Corredor A, Arciniegas E, Hernández CA (Eds). Parasitismo intestinal. Ministerio de Salud, Instituto Nacional de Salud. Bogotá: Instituto Nacional de Salud. 2000; pp. 67-8.
8. Instituto Nacional de Salud, Secretaría de Salud del Cauca, Universidad Nacional de Colombia, Programa para la Eliminación de la Oncocercosis en las Américas (OEPA). Evolución Epidemiológica del Foco de Oncocercosis en Colombia. Informe para el Ministerio de Protección Social de Colombia, Bogotá; Julio 2007.
9. González A, Sahagún AM, Diez MJ, Fernández N, Sierra M, García JJ. The Pharmacokinetics and Interactions of Ivermectin in Humans-A Mini-review. The AAPS Journal. 2008;10:42-6.
10. Heukelbach J, Winter B, Wilcke T, Muehlen M, Albrecht S, de Oliveira FA, Kerr-Pontes LR, Liesenfeld O, Feldmeier H. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ. 2004;82(8):562.
11. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, Biligui S, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994;88(3):344-5.
12. Speare R, Durrheim D. Mass treatment with ivermectin: an underutilized public health strategy. Bull World Health Organ. 2004;82(8):562.
13. Gann PH, Neva FA, Gam AA. A randomized trial of single-and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis. 1994;169(5):1076-9.
14. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health. 2000;31(1):147-51.
15. Adenusi AA, Oke AO, Adenusi AO. Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection. Afr J Biotechnol. 2003;2:465-9.
16. Gutman J, Emukah E, Okpala N, Okoro C, Obasi A, Miri ES, et al. Effects of annual mass treatment with ivermectin for onchocerciasis on the prevalence of intestinal helminths. Am J Trop Med Hyg. 2010;83(3):534-41.
17. Moncayo AL, Vaca M, Amorim L, Rodriguez A, Erazo S, Oviedo G, et al. Impact of longterm treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections. PLoS Negl Trop Dis. 2008;2(9):1-9.
18. Maegga BTA, Malley KD, Mwiwula V. Impact of ivermectin mass distribution for onchocerciasis control on Ascaris lumbricoides among schoolchildren in Rungwe and Kyela Districts, southwest Tanzania. Tanzania Health Research Bulletin. 2006;8(2):70-4.
19. Behnke JM, Pritchard DI, Wakelin D, Park JR, McNicholas AM, Gilbert FS. Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone. J Helminthol. 1994;68(3):187-95.
20. Habicht JP, Victora CG, Vaughan JP Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int. J. Epidemiol. 1999;28(1):10-18.
21. Holdridge LR. Ecología basada en zonas de vida. Instituto Interamericano de Ciencias Agrícolas San José, Costa Rica, MCA.1979; p. 216.
22. Beck JW, García A, Jartog EM, Shaner AL. Empleo de la técnica de recuento de huevos de Ritchie-Frick en el estudio de la efectividad del antihelmíntico nopar (Yoduro de stilbazium). Rev Fac Med Univ Nac Colomb.1965;14:33-36.
23. Zocchetti C, Consonni D, Bertazzi PA. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. Int J Epidemiol. 1997;26(1):220-3.
24. Schiaffino A, Rodríguez M, Pasarín MI, Regidor E, Borrell C, Fernández E. ¿Odds ratio o razón de proporciones?: Su utilización en estudios transversales. Gac Sanit. 2003 17(1): 70-4. [Internet] Disponible en: http://scielo.isciii.es/scielo.php?script=sci_ arttext&pid= S0213-91112003000100012&lng=es. Consultado mayo de 2011.
25. World Medical Association Declaration of Helsinki. Ethical principles for medical reseearch involving human subjects. Latest revision. 52nd WMA General Assembly, Seoul. October 2008. [Internet] Disponible en: http://www.wma.net/ en/30publications/10policies/b3/17 c.pdf. Consultado mayo de 2011.
26. Congreso de la República de Colombia. Ley 1098. 2006.
27. Ministerio de Salud. Dirección de desarrollo científico y tecnológico. Normas científicas, técnicas y administrativas para la investigación en salud. Resolución No 008430 de 1993. Santafé de Bogotá.
28. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, Biligui S, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg. 1994;88(3):344-5.
29. Speare R, Durrheim D. Mass treatment with ivermectin: an underutilized public health strategy. Bull World Health Organ. 2004;82(8):562.
30. World Health Organization (WHO). Partnership for parasite control, 2002; WHO Deworming for Health and Development; 2005.